Stage
No active trials
Next date
None yet
Trials
0 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Smallpox
- Main trialPhase 4
- “Safety and PK study in adults weighing more than 120 kg”In the company’s words, NCT04392739 on ClinicalTrials.gov
Other drugs for Smallpox
- TecovirimatSIGA Technologies · Phase 2
- BNT166aBioNTech · Phase 2
- BSY001China National Biotec Group Company Limited · Phase 1
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 4Completed | 5 Dec 2019 | Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026